Pharmacokinetics of sulfamethoxazole and trimethoprim in donkeys, mules, and horses

American Journal of Veterinary Research

Volumn 63, Issue 3, 2002, Pages 349-353

  Peck, Kenneth E ^a   Matthews, Nora S ^a   Taylor, Tex S ^a   Mealey, Katrina L ^a  

^a TEXAS A AND M UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SULFAMETHOXAZOLE; TRIMETHOPRIM;

ANIMAL EXPERIMENT; ANTIBACTERIAL ACTIVITY; AREA UNDER THE CURVE; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DONKEY; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG ELIMINATION; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HORSE; MALE; MEAN RESIDENCE TIME; MULE; NONHUMAN; PERISSODACTYLA; STEADY STATE;

ANIMALIA; EQUIDAE; EQUUS ASINUS; EQUUS CABALLUS; PERISSODACTYLA;

EID: 0036521406     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: 10.2460/ajvr.2002.63.349     Document Type: Article

References (18)

1. Plumb DC. Drug monographs-sulfa/trimethoprim. In: Veterinary drug handbook. 3rd ed. Ames, Iowa: Iowa State University Press, 1999;586-589.
2. Van Duijkeren E, Vulto A, Sloet Van Oldruitenborgh-Osterbaan M, et al. Pharmacokinetics of trimethoprim/sulphachlorpyridazine in horses after oral, nasogastric and intravenous administration. J Vet Pharmacol Ther 1995;18:47-53.
3. Horspool L, McKellar Q. Disposition of oxytetracycline in horses, ponies and donkeys after intravenous administration. Equine Vet J 1990;22:284-285.
4. Horspool L, Sarasola P, McKellar Q. Disposition of ampicillin sodium in horses, ponies and donkeys after intravenous administration. Equine Vet J 1992;suppl 11:59-61.
5. Welfare R, Mealey K, Matthews N, et al. Pharmacokinetics of gentamicin in donkeys. J Vet Pharmacol Ther 1996;19:167-169.
6. Lavy E, Ziv G, Glickman A. Intravenous disposition kinetics, oral and intramuscular bioavailability and urinary excretion of norfloxacin nicotinate in donkeys. J Vet Pharmacol Ther 1995;18:101-107.
7. Horspool L, McKellar Q. Disposition of pencillin G sodium following intravenous and oral administration to equidae. Br Vet J 1995;151:401-412.
8. Horspool L, Taylor D, McKellar Q. Plasma disposition of amikacin and interactions with gastrointestinal microflora in equidae following intravenous and oral administration. J Vet Pharmacol Ther 1994;17:291-298.
9. Saini N, Chaudhary R, Rampal S, et al. Pharmacokinetics and dosage regimen of sulphadimidine in donkeys following intravenous administration. Indian J Anim Sci 1997;67:406-407.
10. Brown M, McCartney J, Gronwall R, et al. Pharmacokinetics of trimethoprim-sulphamethoxazole in two-day-old foals after a single intravenous injection. Equine Vet J 1990;22:51-53.
11. Van Duijkeren E, Vulto A, Sloet Van Oldruitenborgh-Oosterbaan M, et al. A comparative study of the pharmacokinetics of intravenous and oral trimethoprim/sulfadiazine formulations in the horse. J Vet Pharmacol Ther 1994;17:440-446.
12. Oukessou M, Alsouss I. Pharmacokinetics of sulfonamides and trimethoprim in the donkey (Equus asinus). J Vet Med Assoc 1998;45:191-198.
13. Brown MP, Gronwall R, Castro L. Pharmacokinetics and body fluid and endometrial concentrations of trimethoprim-sulfarnethoxazole in mares. Am J Vet Res 1998;49:918-922.
14. Matthews NS, Peck KE, Mealey KL, et al. Pharmacokinetics and cardiopulmonary effects of guaifenesin in donkeys. J Vet Pharmacol Ther 1997;20:442-446.
15. Mealey KL, Matthews NS, Peck KE, et al. Comparative pharmacokinetics of phenylbutazone and its metabolite oxyphenbutazone in clinically normal horses and donkeys. Am J Vet Res 1997;58:53-55.
16. Benet LZ, Oie S, Schwartz JB. Design and optimization of dosage regimens; pharmacokinetic data (appendix II). In: Hardman JG, Limbird LE, eds. The pharmacological basis of therapeutics. New York: McGraw-Hill Book Co, 1996;1707-1792.
17. Veng-Pederson P. Mean time parameters in pharmacokinetics: definition, computation and clinical implications (part II). Clin Pharmacokinet 1989;17:424-440.
18. Mandell GI, Petri WA. Sulfonamides, trimethoprim-sulfamethoxazole, quinolones, and agents for urinary tract infections. In: Hardman JG, Limbird LE, eds. The pharmacological basis of therapeutics. New York: McGraw-Hill Book Co, 1996;1057-1072.